Richard W. Hunt
2009
In 2009, Richard W. Hunt earned a total compensation of $341.9K as Former Chief Financial Officer at Osiris Therapeutics, a 67% decrease compared to previous year.
Compensation breakdown
| Option Awards | $110,565 |
|---|---|
| Salary | $231,289 |
| Total | $341,854 |
Hunt received $231.3K in salary, accounting for 68% of the total pay in 2009.
Hunt also received $110.6K in option awards.
Rankings
In 2009, Richard W. Hunt's compensation ranked 8,007th out of 9,885 executives tracked by ExecPay. In other words, Hunt earned more than 19.0% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 8,007 out of 9,885 | 19th |
Division Manufacturing | 3,005 out of 3,690 | 19th |
Major group Chemicals And Allied Products | 691 out of 871 | 21st |
Industry group Drugs | 498 out of 643 | 23rd |
Industry Biological Products, Except Diagnostic Substances | 93 out of 138 | 33rd |
Source: SEC filing on April 16, 2010.
Hunt's colleagues
We found five more compensation records of executives who worked with Richard W. Hunt at Osiris Therapeutics in 2009.
2009
C Mills
Osiris Therapeutics
Chief Executive Officer
2009
Lode Debrabandere
Osiris Therapeutics
Senior Vice President,
2009
Therapeutics Williams
Osiris Therapeutics
Chief Scientific Officer
2009
Philip Jacoby
Osiris Therapeutics
Chief Financial Officer
2009
Harry Carmitchel
Osiris Therapeutics